Longevity
The Senescence-Cancer Crossover: A Metabolic Brake on Aging Cells
New 2025 research reframes senescent and tumor cells as biological cousins — and points to putrescine as an unexpected checkpoint in how cells decide to age.
Press Enter to search · Esc to close
New 2025 research reframes senescent and tumor cells as biological cousins — and points to putrescine as an unexpected checkpoint in how cells decide to age.
A tiny structure inside every cell may act as a countdown timer for lifespan — and a new wave of AI-guided drug discovery and senescence-targeting therapies is racing to slow it down.
Three 2025 papers are quietly reshaping the science of why we age — and where the next generation of interventions may aim. Here is what to know, and what to hold loosely.
Two new studies sharpen the picture of mTOR as an aging lever — pointing toward more precise ways to dial it down than blunt suppression.